Avinger Competitors

Delisted . USA . 
Stock . Avinger
AVGRDelisted Stock  USD 0.47  0.09  16.07%   
Avinger competes with GlucoTrack, Nexgel, Sharps Technology, Innovative Eyewear, and AngioDynamics; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Avinger competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Avinger to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Avinger competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.030.5226.30
Details
Intrinsic
Valuation
LowRealHigh
0.020.4526.23
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Avinger. Your research has to be compared to or analyzed against Avinger's peers to derive any actionable benefits. When done correctly, Avinger's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Avinger.

Avinger Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Avinger and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Avinger and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Avinger does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
STSS
+ 0.85
GCTK
MLSS
+ 0.85
ANGO
ICUI
+ 0.82
AKYA
LUCY
+ 0.8
STSS
NXGL
+ 0.79
GCTK
MLSS
+ 0.78
ATRC
  
High negative correlations   
ATRC
- 0.75
GCTK
ATRC
- 0.68
STSS
ATRC
- 0.59
NXGL
MLSS
- 0.58
GCTK
MLSS
- 0.44
NXGL
ANGO
- 0.43
GCTK

Risk-Adjusted Indicators

There is a big difference between Avinger Stock performing well and Avinger Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Avinger's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GCTK  8.80 (3.03) 0.00 (30.28) 0.00 
 0.00 
 19.55 
(24.47)
 77.82 
NXGL  4.02  0.10  0.00 (0.09) 0.00 
 0.00 
 9.22 
(7.95)
 27.48 
STSS  8.54 (1.55) 0.00  0.56  0.00 
 0.00 
 19.35 
(18.18)
 76.46 
LUCY  4.19 (0.53) 0.00 (0.55) 0.00 
 0.00 
 7.18 
(9.27)
 28.66 
ANGO  3.28  0.62  0.21  0.85  2.86 
(4.26)
 4.93 
(4.95)
 46.09 
ATRC  2.13  0.14  0.00 (0.02) 0.00 
 0.00 
 4.56 
(4.77)
 16.13 
AKYA  3.89 (0.44) 0.00  1.40  0.00 
 0.00 
 6.61 
(7.04)
 25.17 
ATR  0.90 (0.14) 0.00 (0.32) 0.00 
 0.00 
 1.46 
(1.87)
 10.88 
ICUI  1.69 (0.01) 0.00 (0.15) 0.00 
 0.00 
 3.44 
(3.61)
 12.19 
MLSS  4.15  0.47  0.09  0.40  4.68 
(4.92)
 9.88 
(8.11)
 37.01 
All Fundamental Data

Avinger Competitive Analysis

The better you understand Avinger competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Avinger's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Avinger's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AVGR GCTK NXGL STSS LUCY ANGO ATRC AKYA ATR ICUI
 16.07 
 0.47 
Avinger
 5.71 
 0.37 
GlucoTrack
 0.36 
 2.79 
Nexgel
 8.11 
 0.34 
Sharps
 2.61 
 3.73 
Innovative
 1.21 
 9.01 
AngioDynamics
 1.68 
 33.31 
AtriCure
 1.35 
 1.50 
Akoya
 1.31 
 146.66 
AptarGroup
 2.33 
 143.45 
ICU
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Risky
Dangerous
Relatively risky
Slightly risky
Very steady
Dangerous
Very steady
Very steady
Market Performance
(90 Days Performance)
OK
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Very High
Above Average
Very High
Below Average
Low
Low
Very High
Very Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Buy
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Hold
Strong Sell
Strong Sell
Buy
Buy
Strong Sell
Strong Hold
Strong Hold
Current Ratio
3.48
4.52
4.33
2.64
0.34
2.28
3.66
3.55
1.56
2.45
Net Asset
13.77 M
4.91 M
9.96 M
11.79 M
6.22 M
317.67 M
609.33 M
180.37 M
4.43 B
4.2 B
Profit Margin
-2.56
N/A
-0.52
N/A
N/A
-0.78
-0.0961
-0.67
0.1
-0.0494
EBITDA
(16.35 M)
(7.09 M)
(2.73 M)
(8.98 M)
(6.58 M)
(14.29 M)
(18.53 M)
(45.63 M)
777.45 M
42.96 M
Operating Margin
-2.22
N/A
-0.27
N/A
-6.95
-0.0696
-0.12
-0.39
0.14
0.0731
Current Valuation
1.21 M
5.64 M
22.71 M
3.17 M
5.75 M
331.25 M
1.55 B
122.39 M
10.56 B
4.8 B
Price To Book
0.39
21.4
4.38
0.51
0.85
2.04
3.47
5.38
3.93
1.77
Retained Earnings
(420.7 M)
(109.85 M)
(14.71 M)
(25.15 M)
(16.97 M)
(395.2 M)
(401.75 M)
(230.07 M)
2.37 B
690.16 M
Current Asset
51.06 M
N/A
N/A
N/A
7.51 M
146.25 M
74.75 M
N/A
519.72 M
505.01 M
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.27
N/A
Beta
1.1
-0.3
0.62
1.19
2.74
0.56
1.54
1.32
0.55
0.74
Number Of Employees
68
6
19
57
11
748
1.3 K
330
13.5 K
15 K
Shares Outstanding
3.2 M
10.41 M
6.79 M
1.8 M
2.44 M
40.47 M
48.88 M
49.57 M
66.5 M
24.52 M
Cash Flow From Operations
(14.43 M)
(6.56 M)
(3.24 M)
(8.51 M)
(5.77 M)
(28.16 M)
12.2 M
(50.9 M)
643.41 M
204.03 M
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0123
N/A
Total Debt
15.39 M
196 K
2.8 M
3.85 M
659.94 K
5.91 M
76.53 M
85.71 M
1.08 B
1.58 B
Return On Equity
-14.76
-19.43
-0.68
-1.03
-0.87
-0.76
-0.0964
-1.53
0.16
-0.0576
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.7
-2.04
-0.24
-0.52
-0.53
-0.0584
-0.0409
-0.18
0.072
0.0142
Number Of Shares Shorted
132.01 K
104.5 K
106.35 K
899.23 K
46.9 K
1.65 M
1.28 M
3.25 M
756.49 K
786.38 K
Book Value Per Share
1.39
-13.94
0.69
11.43
4.51
4.57
9.43
0.28
37.2
80.16
Current Liabilities
7.48 M
N/A
N/A
N/A
5.78 M
66.73 M
31.59 M
N/A
411.89 M
42.62 M
Total Asset
13.77 M
4.91 M
9.96 M
11.79 M
6.22 M
317.67 M
609.33 M
180.37 M
4.43 B
4.2 B
Debt To Equity
3.26
0.06
0.36
0.56
N/A
0.14
0.16
0.62
0.63
0.84
Short Ratio
0.15
0.2
1.52
0.38
1.83
2.86
2.57
9.67
1.68
3.55
Target Price
5.0
N/A
6.0
352.0
14.0
15.33
54.22
3.48
177.0
190.0
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.72
N/A
Shares Owned By Institutions
10.16
0.43
6.19
4.02
0.88
84.69
97.96
70.19
92.95
99.48
Market Capitalization
1.52 M
3.63 M
18.88 M
5.81 M
9.35 M
369.05 M
1.6 B
73.37 M
9.63 B
3.44 B
Price To Earning
-0.13
N/A
N/A
N/A
N/A
7.9
33.47
N/A
28.95
38.71
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
1.87
-1.18
N/A
4.52
1.7
Price To Sales
0.21
N/A
2.81
N/A
5.99
1.29
3.44
0.85
2.69
1.44
Net Income
(18.32 M)
(7.1 M)
(3.16 M)
(9.84 M)
(6.66 M)
(184.35 M)
(44.7 M)
(63.32 M)
374.18 M
(117.69 M)
Earnings Per Share
-8.76
-58.2
-0.59
-8.24
-10.1
-5.59
-0.95
-1.16
5.53
-4.83
Shares Owned By Insiders
7.94
2.33
20.56
3.7
51.5
5.62
3.49
67.54
0.56
7.83
Revenue
7.65 M
N/A
4.09 M
N/A
1.15 M
303.91 M
465.31 M
96.63 M
3.58 B
2.38 B
Working Capital
(7.14 M)
3.36 M
2.5 M
1.15 M
4.99 M
102.1 M
194.4 M
86.44 M
410.1 M
885.8 M
Cash And Equivalents
17.34 M
3.85 M
9.79 M
7.81 M
34.88 K
24.56 M
118.45 M
87.61 M
141.73 M
285.59 M
Cash Per Share
2.33
0.25
1.76
0.85
N/A
0.31
2.55
2.31
1.91
11.95
Gross Profit
1.52 M
(20 K)
2.13 M
N/A
(58.68 K)
151.01 M
347.52 M
50.11 M
1.36 B
824.78 M
Day Typical Price
0.51
0.36
2.79
0.36
3.71
9.08
33.19
1.59
146.03
141.34
Accumulation Distribution
0.25
29508.65
2323.44
1.2 M
608.45
8569.01
23114.26
38243.09
3576.99
9985.28
Market Facilitation Index
0.15
N/A
0.0
N/A
0.0
0.0
0.0
0.0
0.0
0.0
Daily Balance Of Power
(0.60)
0.5
0.0556
(0.43)
(0.53)
(0.33)
0.44
0.0667
0.8085
0.4312
Period Momentum Indicator
(0.09)
0.02
0.01
(0.03)
(0.10)
(0.11)
0.55
0.02
1.9
3.26
Rate Of Daily Change
0.84
1.06
1.0
0.92
0.97
0.99
1.02
1.01
1.01
1.02
Day Median Price
0.54
0.35
2.79
0.38
3.7
9.11
33.14
1.63
145.71
140.28
Price Action Indicator
(0.11)
0.03
0.005
(0.05)
(0.01)
(0.16)
0.45
(0.12)
1.9
4.8
Coefficient Of Variation
2752.18
(451.48)
(2,991)
(1,199)
(776.13)
1141.08
(15,450)
(1,240)
(606.07)
(1,740)
Mean Deviation
10.38
8.8
4.02
8.54
4.19
3.28
2.13
3.89
0.8968
1.69
Jensen Alpha
1.1
(3.03)
0.1025
(1.55)
(0.53)
0.6249
0.1434
(0.44)
(0.14)
(0.01)
Total Risk Alpha
4.29
(0.74)
0.6749
1.24
0.2073
1.58
0.4647
0.4161
(0)
0.2453
Sortino Ratio
0.0708
N/A
N/A
N/A
N/A
0.2138
N/A
N/A
N/A
N/A
Downside Variance
159.59
N/A
N/A
N/A
N/A
10.04
N/A
N/A
N/A
N/A
Standard Deviation
20.99
13.71
5.07
14.72
5.48
6.22
2.93
4.85
1.44
2.3
Kurtosis
19.85
3.85
0.7717
8.11
0.4165
21.47
1.37
0.1604
15.77
2.35
Potential Upside
33.33
19.55
9.22
19.35
7.18
4.93
4.56
6.61
1.46
3.44
Treynor Ratio
0.3077
(30.28)
(0.09)
0.5616
(0.55)
0.851
(0.02)
1.4
(0.32)
(0.15)
Maximum Drawdown
156.92
77.82
27.48
76.46
28.66
46.09
16.13
25.17
10.88
12.19
Variance
440.56
187.85
25.71
216.54
30.01
38.73
8.58
23.53
2.08
5.29
Market Risk Adjusted Performance
0.3177
(30.27)
(0.08)
0.5716
(0.54)
0.861
(0.01)
1.41
(0.31)
(0.14)
Risk Adjusted Performance
0.0403
(0.18)
(0.02)
(0.06)
(0.10)
0.0826
0.0017
(0.06)
(0.14)
(0.04)
Skewness
3.57
0.5138
0.2727
(0.49)
0.0724
4.04
0.1511
0.2264
(2.91)
(0.25)
Semi Deviation
11.53
N/A
N/A
N/A
N/A
2.86
N/A
N/A
N/A
N/A
Information Ratio
0.0426
(0.21)
(0.01)
(0.07)
(0.10)
0.1089
0.0387
(0.05)
(0.07)
0.0
Value At Risk
(24.22)
(24.47)
(7.95)
(18.18)
(9.27)
(4.95)
(4.77)
(7.04)
(1.87)
(3.61)
Expected Short fall
(16.33)
N/A
N/A
N/A
N/A
(4.26)
N/A
N/A
N/A
N/A
Downside Deviation
12.63
N/A
N/A
N/A
N/A
3.17
N/A
N/A
N/A
N/A
Semi Variance
132.83
N/A
N/A
N/A
N/A
8.21
N/A
N/A
N/A
N/A

Avinger Competition Performance Charts

Five steps to successful analysis of Avinger Competition

Avinger's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Avinger in relation to its competition. Avinger's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Avinger in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Avinger's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Avinger, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Avinger position

In addition to having Avinger in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Medical Equipment Thematic Idea Now

Medical Equipment
Medical Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Medical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Medical Equipment Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in Avinger Stock

If you are still planning to invest in Avinger check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avinger's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY